DarioHealth (NASDAQ:DRIO) Shares Cross Below 200-Day Moving Average of $1.65

Shares of DarioHealth Corp. (NASDAQ:DRIO) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.65 and traded as low as $1.15. DarioHealth shares last traded at $1.18, with a volume of 61,199 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Stifel Nicolaus reissued a “buy” rating and set a $4.00 price objective on shares of DarioHealth in a research report on Monday, April 1st.

DarioHealth Stock Performance

The company has a market capitalization of $35.31 million, a price-to-earnings ratio of -0.70 and a beta of 1.53. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.95 and a quick ratio of 2.67. The stock has a 50 day simple moving average of $1.44 and a two-hundred day simple moving average of $1.65.

DarioHealth (NASDAQ:DRIO) last issued its earnings results on Wednesday, May 15th. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.39. The business had revenue of $5.76 million for the quarter, compared to analyst estimates of $5.95 million. DarioHealth had a negative return on equity of 76.11% and a negative net margin of 282.38%. As a group, analysts anticipate that DarioHealth Corp. will post -1.53 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of DRIO. Appian Way Asset Management LP lifted its position in DarioHealth by 0.9% in the first quarter. Appian Way Asset Management LP now owns 1,334,142 shares of the company’s stock valued at $2,041,000 after acquiring an additional 11,698 shares during the last quarter. Walleye Capital LLC acquired a new stake in shares of DarioHealth during the third quarter worth about $3,968,000. Finally, Clarity Capital Partners LLC lifted its holdings in shares of DarioHealth by 20.1% in the 1st quarter. Clarity Capital Partners LLC now owns 204,758 shares of the company’s stock valued at $313,000 after purchasing an additional 34,332 shares during the last quarter. Institutional investors and hedge funds own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.